10x Genomics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TXG Nasdaq 2836 www.10xgenomics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for 10x Genomics, Inc.

Multiomics Market Report Now Available — See Why Spatial Omics Is Set to Outgrow Single-Cell as the Field's Next Growth Driver - Sep 8th, 2026 9:51 am
3 Inflated Stocks with Open Questions - Sep 4th, 2026 3:42 am
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - Sep 3rd, 2026 11:51 am
10x Genomics Needs "Meaningful' Growth in Single-Cell Business, RBC Says - Sep 1st, 2026 9:22 am
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences - Aug 31st, 2026 11:12 am
Sector Update: Healthcare Stocks Decline Late Afternoon - Aug 28th, 2026 2:06 pm
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences - Aug 28th, 2026 12:38 pm
3 Small-Cap Stocks with Open Questions - Aug 25th, 2026 4:54 am
10x Genomics (TXG) Sees Strong Early Orders for New Atera Platform - Aug 18th, 2026 1:44 am
10x Genomics (TXG) Could Be 35% Above Fair Value Following 2026 Outlook Lift - Aug 16th, 2026 6:08 am
5 Revealing Analyst Questions From 10x Genomics’s Q2 Earnings Call - Aug 15th, 2026 1:41 am
1 High-Flying Stock to Own for Decades and 2 We Question - Aug 14th, 2026 2:37 pm
10x Genomics (TXG) Q2 2026 Earnings Call Transcript - Aug 14th, 2026 8:36 am
1 Unpopular Stock That Deserves Some Love and 2 That Underwhelm - Aug 10th, 2026 9:49 am
TXG Q2 Deep Dive: Atera Launch Signals Transition as Spatial Market Shifts - Aug 9th, 2026 9:41 pm
10x Genomics Q2 Earnings Call Highlights - Aug 7th, 2026 1:04 pm
10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up - Aug 7th, 2026 11:57 am
10x Genomics, Inc. Q2 2026 Earnings Call Summary - Aug 7th, 2026 6:30 am
10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - Aug 6th, 2026 3:45 pm